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Abstract. Cardiovascular disease cases increase due to consumption 
cholesterol dietary habit. It is well-known that squalence synthase 
(SQS) is the first committed enzyme for cholesterol synthesis. 
Therefore, SQS become target of anti-cholesterol. This paper aims to 
determine the potential binding pocket of SQS (PDB ID: 1EZF). 
Dogsitescorer, siteFinder, and DEPTH were used for binding pocket 
prediction and MOE 2009.10 was performed for molecular docking. 
We found that there are five out of 37 pockets which have 
druggability score above 0.8. Pocket_5 is the highest drugability and 
favorable for hydrophobic interaction, yet lower number of hydrogen 
bond with the ligand. However, Pocket_2, and Pocket_3 are suitable 
for hydrogen bond formation of ligand-protein. Molecular docking 
study showed that TAK-475, D99, and Cynarin inhibitors were 
embedded on the P_2 and P_3 of SQS, showing that P2_and P3 are 
promising binding pocket for ligand interactions. These results show 
a promising alternative to design anti-cholesterol using these 
potential pocket in silico. 
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1. Introduction 
High levels of cholesterol in dietary increases the risks of heart disease and stroke [1]. It has been 
reported by WHO that around 17 million people die by heart disease and stroke [2]. The prevalence 
of cholesterol cases increasing is closely related to the country's economy. WHO reports that 
cholesterol cases in high-income countries increase more than 50% of adults, whereas, in low-
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The current hypercholesterol treatments include low cholesterol diet, exercise, inhibitors of 
cholesterol adsorbtion, and inhibitors of cholesterol synthesis [3]. The most advanced anti-
cholesterol drug against HMG-CoA reductase, statin family, showed undesirable side effects. Statins 
produce statin-induced myotoxicity (SIM) manifest with severe muscle weakness, muscle pain, and 
muscle tenderness [4]. In addition, HMG-CoA reductase inhibition prevents mevalonate synthesis 
which is imporant precursor for dolichol, ubiquinone, and RAS [5].  
Currently, a promising strategy for blocking cholesterol synthesis is the development of inhibitor 
for Squalene synthase (SQS). SQS plays an important role as an enzyme for  cholesterol biosynthesis 
which catalyzes the first step of the steroid synthesis pathway [6]. Clinical studies have shown that 
inhibition of SQS are effective in lowering serum cholesterol concentrations and LDL-C without 
interrupting isoprenoid production [7][8]. Moreover, SQS inhibitors have have fewer secondary 
effects than HMG-CoA reductase inhibitors[9] Due to its main role and strategic location in 
cholesterol synthesis, SQS is potential drug target for the treatment of cholesterol disease.  
In order to design the new SQS inhibitors, in silico strategies is considered as the first step of 
drug development strategy. Huang et.al (2019) reported that three out of 373,782 inhibitors were 
identified as potential inhibitors of SQS using in silico screening and in vitro studies[6]. Other 
studies on traditional chinese medicine showed that cynarin, D99, and TAK-475 inhibitors had 
strong binding in the dynamic system with SQS protein (PDB ID: 3ASX) [7]. Most of these docking 
studies utilized blind docking. Blind docking, a method for ligand-protein binding prediction, can be 
used for mapping of drug development.  A key advantage of blind docking is the capability to 
predict the binding without any prior knowledge of the target pocket [10]. However, limitations of 
blind docking are the unknown number of trials and energy evaluations. It is recommended that 
more than 100 times of trial, and 10 million energy evaluations [11]. Due to these limitation, 
therefore, in the in silico drug discovery, the identification of ligand-protein binding pocket is the 
first stage, followed by hit identification, lead optimization, and ADMET properties calculation 
[12][13]. Recently, docking protocol using known binding pocket increases accuracy and efficiency 
than blind docking only with the lower time of trial [14]. Thus, the present study aimed to determine 
the most potential pocket of squalene synthase for cholesterol synthesis inhibition.  
 
2. Method 
2.1. Hardware, Software and Webserver 
Personal laptop HP model 14-ck0011TU Intel® Celeron® N4000 CPU 1.1GHz, RAM 4.0 GB, 
Microsoft Windows 10 Pro 64-bit with internet connection. MOE 2009.10 software (Chemical 
Computing Group ULC). Webserver http://www.rcsb.org/pdb/, https://proteins.plus/, and 
http://cospi.iiserpune.ac.in/depth. 
2.2. Material  
Human squalene synthase (PDB ID: 1EZF) was obtained from the Protein Data Bank (PDB) 
database (http://www.rcsb.org/pdb/). Ligands structure of TAK-475, D99, and cynarine were 
retrieved from Pubchem database (https://pubchem.ncbi.nlm.nih.gov/) with the CID : 9874248, 
54669582, and 5281769, respectively. 
2.3. SQS Binding Pocket Analysis  
 To predict the binding pocket of human squalene synthase, we have performed the binding 






Fitri Amelia, Basultan Hidayat, Iryani, Iswendi 
 
[16], and Depth server (http://cospi.iiserpune.ac.in/depth) [17] were used to measure the volume, 
druggability, and polarity of the pockets. 
2.4. Molecular Docking and Binding Analysis  
To further identify the potential binding pocket for inhibitors of human squalene synthase, we 
have docked  1EZF with TAK-475, D99, and cynarine. Ligands were optimized using MOE 
2009.10 [18]. Preparation of Human squalene synthase was carried out using MOE 2009.10 
software. The native ligands and water molecules were separated from the human SQS structure 
(PDB ID: 1EZF) and optimized using current forcefield, adjust hydrogen and lone pairs, gradient 
0,05, and forcefield partial charges calculation [19]. The docking study was performed by MOE 
2009.10 software, which uses; triangle matcher with 2500000 iterations as placement, one-time 
rescoring, London dG, 100 repetitions for the first retain, and force field refinement [18] [19].  
 
Figure 1. The protocol Utilized in this study for discovering potential pockets 
3. Results and Discussion 
Binding pocket determination is important to increases accuracy and efficiency in molecular 
docking. In this study, we analysed the drugability, volume, and polarity of pockets, and ligand-
protein interaction to predict the potential binding pocket. SQS structure (PDB ID: 1EZF) was 
utilized to analyse the drugability, volume, and polarity of pockets. The cutoff of 0.7 was used for 
druggability score as the based on the average score [20]. 
Dogsitescorer result showed that there are seven pockets out of fifteen which have the drugable 
score > 0.70 and also have a high number of volume (Table 1), indicating discerning between the 
druggable and non-druggable pockets. The pocket volume increase with the increase of drugability 
(Table 1). Volume is important variable for druggable prediction, which is individually calculated 
using the number of volume grid points and grid spacing [21]. However, pocket 5 (P_5) having low 
pocket volume reached the highest drugability score. It might be due to the percentage of 
hydrophobic (nonpolar) area is higher than hydrophilic area, but not too different. A similar 
phenomenon in which SARS-Cov-2 S-glycoprotein binding pocket prediction has been reported 
previously [22]. Previous report highlighted that water molecules trapped inside the binding site is 
crucial for hydrophobicity and hydrophilicity of the binding site. Therefore, maintaining the water 
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Table 1. Potential binding pockets of Squalene synthase (PDB ID: 1EZF) based on 
Drugable score analysed by Dogsitescorer server 
Pocketa Drugable score Volume (A3) 




P_5 0.84 536.59 46 40 14 
P_0 0.83 768.73 48 22 30 
P_1 0.83 731.62 45 24 31 
P_2 0.81 609.07 64 28 8 
P_3 0.80 560.22 58 35 8 
P_4 0.79 541.14 60 32 8 
P_6 0.75 523.64 37 19 45 
P_7 0.66 306.72 35 40 25 
P_12 0.63 211.83 62 31 8 
P_11 0.62 237.40 32 42 26 
P_9 0.60 278.89 23 69 8 
P_10 0.60 266.81 69 31 0 
P_8 0,59 298.49 65 29 6 
P_13 0.54 211.48 33 47 20 
P_14 0.43 206.58 33 33 34 
 aPocket 1, Pocket 2, etc are shown as P_1, P_2, etc  
In order to provide better discerning between the druggable and non-druggable pockets, we next 
utilized the pockets which have score  0.8. Binding pocket analysis were confirmed using sitefinder 
MOE, and Depth. Table 2 showed that all the pockets  have more hydrophobic residues rather than 
hydrophilic. Unlike P_0, P_1 and P_5, dogscorer and sitefinder analysis result on P_2 and P_3 were 
similar. Previous study revealed that the similarity results of the dogscore and sitefinder analysis 
result in better complex ligand and protein interaction [22].  
To confirm the capability of pockets as binding pocket, we docked all five pocket with TAK-475, 
D99, dan cynarin ligand. H-bond residues for SQS were provided in Tables 3. We showed that there 
are more hydrogen bonds than hydrophobic interaction. Consistently, Ligand-OppA protein 
interaction was achieved by utilizing the hydrogen bonds and the electrostatic forces[23]. Moreover, 
other findings revealed that hydrogen bonds are considered as the main facilitators of protein-ligand 
interaction [24]. The present study showed that TAK-475 has the highest number of hydrogen bonds 
in P_3, while cynarin has high number of hydrogen bonds in P_1 and P_5. Taken together, these 
results suggest that P_2 and P_3 are potential as binding pocket. As the ligands are completely 
embedded within the pocket protein Figure 1, physiochemical properties of ligand are important to 
consider ligand-protein interaction. Both TAK-475 and cynarin have high number of hydrogen 
acceptors and donors, suggesting strong protein-ligand interactions due to physicochemical 
properties (Table 4). Our result is supported by a recent study showing that hydrogen acceptor and 
donor of the ligands are the main facilitators of ligand-protein interaction[22]. Therefore, 
physicochemical properties of ligand and pocket hydrophobicities are suggested as the main factor 
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Table 2. Residues of Amino Acid in binding pockets of SQS 
Pocketa Hydrophobicity Charges Special charges 





















































































































































aPocket 1, Pocket 2, etc are shown as P_1, P_2, etc  
b residues with red colour =  predicted by dogsitescorer and sitefindermoe  
cresidues with black colour = predicted by dogsitescorer only  
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TAK-475 -17.1669 TYR_B171 (3.37) ARG_B228 (1.99) ARG_B77 (3.00) 
D99 -15.5290 TYR_B171 (3.06) ARG_B228 (2.05)  
Cynarin -16.1079 





ARG_A52 (2.02) ARG_A77 (2.04) 
LYS_A117 (2.57) GLN_A212 
(1.84) 
- 
D99 -12.6647 ARG_A77 (2.03) ASP_A219 (1.67) PHE_A230 
Cynarin -16.2647 
THR_A81 (3.31) ASP_A118 (2.14) 





TAK-475 -17.3370 ARG_C52 (1.78) LYS_C117 (2.1) - 
D99 -15.8893 ASN_C215 (2.71) LYS_C117 (1.97) 
ARG_C52 
(2.66)(3.16) 
Cynarin -16.3325 ARG_C52 (1.99) VAL_C69 (1.97) - 
P_3 
TAK-475 -14.8776 
ASN_A215 (2.59) SER_A51 (3.41) 
PHE_A54 (1.83) SER_A53 (2.05) 
ARG_A52 (1.92) LYS_A117 
(2.43) 
ARG_A218 
D99 -13.5409 ARG_A52 (1.93) LYS_A117 (2.2) - 
Cynarin -16.0648 
SER_A53 (2.29) TYR_A73 (3.46) 
ARG_A77 (2.38) 
- 
P_5 TAK-475 -12.3923 SER_A53 (3.35) ARG_A52 (3.01) 
 
D99 -12.7368 





LYS_A117 (4.98)(2.19) SER_A51 










MW H Acceptor H Donor 
1 TAK-475 645.1 9 1 
2 D99 549.5 5 2 
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Figure 2. SQS Local Structure of the Docking Complexes: a) TAK-475 with P_3, Cynarin with 
b) P_1 and c) P_5 
4. Conclusion 
In conclusion, we have identified two SQS hydrophobic pocket (P_2, and P_3) as potential 
binding pocket. The findings from molecular docking demonstrated that TAK-475, D99, and 
Cynarin inhibitors are embedded on the P_2 and P_3 of SQS. Complex of inhibitors and P_3 has 
lower binding energy and higher hydrogen bond than that and P_2 of SQS. These findings provide 
promising alternative to design anti-cholesterol.  
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